Detection of Predictive Markers for Therapeutic Stratification of Salivary Glands Tumors

ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)

Volume 18, 16 Issues, 2017

Download PDF Flyer

Current Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 74th of 253 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.029
5 - Year: 3.341

Detection of Predictive Markers for Therapeutic Stratification of Salivary Glands Tumors

Current Drug Targets, 15(8): 785-796.

Author(s): Monica Cantile, Simona Losito, Francesco Longo, Gabriella Aquino, Gabriella Malzone, Franco Fulciniti, Francesco Caponigro, Renato Franco, Franco Ionna and Gerardo Botti.

Affiliation: Pathology Unit, Istituto Nazionale Tumori Fondazione “G. Pascale”, via Mariano Semmola, Naples 80131, Italy.


Malignant tumors of salivary glands are rare lesions, often with poor prognosis. At present, surgery represents the only therapeutic choice, whereas chemotherapy is employed as palliative treatment in advanced disease.

Over the years several molecular alterations associated with the pathogenesis and progression of the salivary glands tumors have been well-characterized. Particularly, the mutational status and/or aberrant expression of certain markers, such as EGFR, HER2, cKIT, BRAF and AR, also identified in some tumor histotypes of the salivary glands, currently represent molecular targets for new and efficacious drugs routinely employed in the treatment of other neoplasias, such as breast, lungs, GIST and melanoma.

The expression analysis of these biomarkers associated with histomorphological data, could then provide the oncologist the opportunity to create a proper stratification of patients for customized therapies.

This review represents an overview of the lesions of the salivary glands best characterized in terms of molecular aspects, focusing the attention on those markers and molecular alterations which can be important in the diagnosis as well as in the therapeutic stratification of these tumors.


Malignant salivary glands tumors, predictive markers, therapeutic stratification.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 15
Issue Number: 8
First Page: 785
Last Page: 796
Page Count: 12
DOI: 10.2174/1389450115666140613104403
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science